RTI Surgical is a medical devices business based in the US. RTI Surgical shares (RTIX) are listed on the NASDAQ and all prices are listed in US Dollars. RTI Surgical employs 935 staff and has a trailing 12-month revenue of around $284.8 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $2.25 |
| 200-day moving average | $2.29 |
| Wall St. target price | $5.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.05 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing RTI Surgical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of RTI Surgical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
RTI Surgical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.39. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into RTI Surgical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
RTI Surgical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.7 million.
The EBITDA is a measure of a RTI Surgical's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $284.8 million |
|---|---|
| Gross profit TTM | $174.7 million |
| Return on assets TTM | -3.42% |
| Return on equity TTM | 0% |
| Profit margin | -90.98% |
| Book value | $0.23 |
| Market Capitalization | $234.2 million |
TTM: trailing 12 months
We're not expecting RTI Surgical to pay a dividend over the next 12 months.
Over the last 12 months, RTI Surgical's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while RTI Surgical's is 2.0319. This would suggest that RTI Surgical's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Surgalign Holdings, Inc. , a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois. .
Use this calculator to quickly see potential outcomes of your options trades.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.